Gima CRP TEST User guide

CRP Test Cassette
Concentrations
Clinical Reference
1.0 mg/L
Low CVD risk
1.03.0 mg/L
Moderate CVD risk (No Inflammation)
3.0 mg/L
High CVD risk (No Inflammation)
10 mg/L
Probable infections (bacterial infections or viral infections)
1020 mg/L
Generally indicates viral infections or mild bacterial infection
2050 mg/L
Generally indicates moderate bacterial infection
50 mg/L
Generally indicates serious bacterial infection
Index of Symbols
Consult instructions for
electroni c
instructions for use
Contains
<n> tests
In vitro diagnostic
medical device
Catalogue
number
Authorized
European Community
Do not use if package is
instructions for use
Hangzhou AllTest Biotech Co., Ltd.
MedNet EC-REP GmbH
Borkstrasse 10 48163 Muenster Germany
(Whole Blood/Serum/Plasma)
Package Insert
A test for the diagnosis of inflammatory condition and ACS by measuring CRP/hs-CRP in whole blood, serum or plasma with the use of Fluorescence Immunoassay Analyzer.
INTENDED USE
SUMMARY
C-reactive protein is an acute-phase reactant that precipitated with Pneumococcal C-polysaccharide, and is a non-specific immune response component. CRP has wide distribution in our body, and is an acute-phase protein produced in the liver in response to microbial infection or tissue injury, it measures general levels of inflammation in the body, and the hs-CRP can be used to detect lower concentrations of CRP in serum or plasma. Studies revealed hs-CRP levels seem to be correlated with Atherosclerosis and Acute Myocardial Infarction. And the hs-CRP is an inflammation “marker” for ACS patient and is helpful for primary prevention and risk assessment of cardiovascular disease. Its combination with the ratio of total cholesterol to HDL-C is more accurate than other risk factors in predicting cardiovascular disease. The American Heart Association and US Centers for Disease Control and Prevention have advocated hs-CRP as a predictor of cardiovascular disease (CVD) to define risk groups: less than 1.0 mg/L indicates low risk, 1.0 to 3.0 mg/L means moderate risk, and the amount above
3.0 mg/L (lower than 10 mg/L) strongly suggests a high risk of CVD. Moreover, higher CRP levels are found in late pregnant women, mild inflammation and viral infections (10~40 mg/L), active inflammation, bacterial infection (40~200 mg/L), severe bacterial infections and burns (>200 mg/L).
PRINCIPLE
CRP Test Cassette is detects CRP based on Fluorescence Immunoassay. The sample moves through the strip from sample pad to absorbent pad. If the specimen contains CRP, it attaches to the fluorescent microspheres-conjugated anti-CRP antibodies. Then the complex will be captured by the capture antibodies coated on the nitrocellulose membrane (Test line). The concentration of CRP in the sample correlates linearly with the fluorescence signal intensity captured on the T line. According to the fluorescence intensity of the test and standard curve, the concentration of CRP in the sample can be calculated by Analyzer to show CRP concentration in specimen.
REAGENTS
The test include anti-CRP antibody coated fluorophore and anti-CRP antibody coated on the membrane.
PRECAUTIONS
1. For professional in vitro diagnostic use only.
2. Do not use after the expiration date indicated on the package. Do not use the test if the foil pouch is damaged. Do not reuse.
3. Avoid cross-contamination of specimens by using a new specimen collection container for each specimen obtained.
4. Do not eat, drink or smoke in the area where the specimens and tests are handled. Handle all specimens as if they contain infectious agents. Observe established precautions against microbiological hazards throughout the procedure and follow standard procedures for proper disposal of specimens. Wear protective clothing such as laboratory coats, disposable gloves and eye protection when specimens are assayed.
5. Do not interchange or mix reagents from different lots.
6. Humidity and temperature can adversely affect results.
7. Used testing materials should be discarded in accordance with local regulations.
8. Read the entire procedure carefully prior to any testing.
9. The CRP Test Cassette should only be used with the Analyzer by approved medical professionals.
STORAGE AND STABILITY
1. The test should be stored at 4-30 °C until the expiry date printed on the sealed pouch.
2. The test must remain in the sealed pouch until use.
3. Do not freeze.
4. Care should be taken to protect the components of the test from contamination.
5. Do not use if there is evidence of microbial contamination or precipitation. Biological contamination of dispensing equipment, containers or reagents can lead to false results.
SPECIMEN COLLECTION AND PREPARATION
Blood Sample Taking
1. Collect the specimens according to standard procedures.
To collect Fingerstick Whole Blood specimens:
Wash the patient’s hand with soap and warm water or clean with an alcohol swab.
Allow to dry. Massage the hand without touching the puncture site by rubbing down the hand towards the fingertip of the middle or ring finger.
Puncture the skin with a sterile lancet. Wipe away the first sign of blood. Gently rub the hand from wrist to palm to finger to form a rounded drop of blood over
the puncture site.
2. Do not leave specimens at room temperature for prolonged periods. Serum and Plasma specimens may be stored at 2-8°C for up to 3 days, for long term storage, specimens should be kept below -20 °C. Whole blood collected by venipuncture should be stored at 2-8 °C if the test is to be used within 2 days of collection. Do not freeze whole blood
REF FI-CRP-402 English
specimens. Whole blood collected by finger stick should be tested immediately.
3. Bring specimens to room temperature prior to testing. Frozen specimens must be completely thawed and mixed well prior to testing. Avoid repeated freezing and thawing of specimens. Only clear, non-hemolyzed specimens can be used.
4. EDTA, Heparin sodium, can be used as the anticoagulant tube for collecting the blood specimen.
Sample Dilution/Sample Stability
1. Administer the blood-filled end-to-end capillary into the plastic tube with buffer. Alternatively, the specimen can be added directly with the micro pipette into the buffer.
2. Close the tube and shake the sample by hand vigorously for approximately 10 seconds to mix the sample and dilution buffer.
3. Let the diluted sample homogenize for approximately 1 minute.
4. The diluted sample can then be used immediately or stored for up to 8 hours.
MATERIALS
Test Cassettes • Specimen Collection Tubes with buffer
ID Card • Package Insert
Droppers • Lancets
• Timer • Centrifuge • Fluorescence Immunoassay Analyzer
• Pipette • Specimen Collection Containers
DIRECTIONS FOR USE
Refer to Fluorescence Immunoassay Analyzer Operation Manual for the complete instructions on use of the Analyzer. The test should be in room temperature.
Allow the test, specimen, buffer and/or controls to reach room temperature (15-30 °C) prior to testing.
1. Turn on the Analyzer power. Then according to the need, select “Standard test” or “Quick test” mode.
2. Take out the ID card and insert it into the Analyzer port.
3. To use a pipette: Pipette 10 μL of sample into the buffer tube; mix the specimen and the buffer well. To use a dropper: Without squeezing the dropper, put the glass capillary tube end in contact with the liquid sample surface tilted. Liquid sample will migrate into the capillary tube automatically. Note: Make sure do not take the plastic part of the dropper in contact with the sample. Then release the sample into the buffer tube by squeezing the bulb at the top end of the dropper vertically. Wash the tube 2-3 times by squeezing the top bulb. Mix the sample and the buffer well.
4. To use a pipette: Pipette 75 μL of diluted specimen into the sample well of the cassette. Start the timer at the same time. To use a dropper: Immerse the tube end (plastic tube) into the diluted sample; squeeze the top bulb to absorb the solution into the lower bulb (no more than the lower bulb). Squeeze the top bulb vertically to release the diluted solution into the sample well of the test cassette and start the timer.
5. There are two test modes for Fluorescence Immunoassay Analyzer, Standard Test mode and Quick Test mode. Please refer to the user manual of Fluorescence Immunoassay Analyzer for details.
Quick test” mode: Insert the test cassette into the Analyzer at 3 minutes after sample
application click “QUICK TEST”, fill the test information and click "NEW T EST" immediately. The Analyzer will automatically give the test result after a few seconds.
Standard test” mode: Insert the test cassette into the Analyzer immediately after sample
application, cl ick “STANDARD TEST ”, fill the test information and click "NEW TEST" at the same time, the Analyzer will automatically counting down 3 minutes. After the countdown, the Analyzer will give the result at once.
INTERPRETATION OF RESULTS
Results read by Fluorescence Immunoassay Analyzer.
The result of tests for C-reactive protein is calculated by Fluorescence Immunoassay Analyzer and display the result on the screen. For additional information, please refer to the user manual of Fluorescence Immunoassay Analyze. Assay range of CRP is 0.5 - 200 mg/L.
QUALITY CONTROL
Each CRP Test Cassette contains internal control that satisfies routine quality control requirements. This internal control is performed each time a sample is tested. This control
Materials Provided
Materials Required But Not Provided
indicates that the test cassette was inserted and read properly by Fluorescence Immunoassay Analyzer. An invalid result from the internal control causes an “N/A” message on Fluorescence Immunoassay Analyzer. Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for control failure. Review the procedure and repeat the test with a new test. If the problem persists, discontinue using the test kit immediately and contact your local distributor.
LIMITATIONS
1. The CRP Test Cassette (Whole Blood/Serum/Plasma) is for professional in vitro diagnostic use, and should only be used for the quantitative detection of C-reactive protein.
2. The CRP Test Cassette (Whole Blood/Serum/Plasma) will only indicate the presence of CRP antigen in the specimen and should not be used as the sole criterion for evaluating inflammatory conditions.
3. As with all diagnostic tests, a confirmed diagnosis should only be made by a physician after all clinical and laboratory findings have been evaluated.
4. High concentrations of CRP may produce a dose hook effect, resulting in incorrect interpretation of CRP levels. High dose hook effect has not been observed with this test up to 200 mg/L of CRP.
5. The test assay range of this test kit is 0.5-200 mg / L. When the concentration of the sample exceeds the upper limit of the test, the high-concentration sample should be diluted with calf serum or negative samples, and the maximum dilution factor should not exceed 4 times.
6. The results of CRP Tests are based on measuring the levels of CRP in a specimen. It should
not be used as the sole criterion for treatment decisions. If the result is positive, other clinical findings and alternative test methods are recommended to reach proper medical treatments.
EXPECTED RESULTS
PERFORMANCE CHARACTERISTICS
1. Accuracy
The test deviation is ≤±15%.
2. Assay Range and Detection Limit
Assay Range: 0.5 – 200 mg/L Minimum Detection Limit (Analytical Sensitivity): 0.5 mg/L
3. Linearity Range
0.5 – 100 mg/L, R≥0.990
4. Precision
Intra-lot precision
Within-run precision has been determined by using 10 replicates of 2 specimens containing 1.0 mg/L, 10.0 mg/L of CRP. C.V. is ≤ 15%.
Inter-lot precision
Between-run precision has been determined by using 10 replicates for each of three lots using 2 specimens containing 1.0 mg/L, 10.0 mg/L of CRP. C.V. is ≤15%
6. Method comparison
The assay was compared with CRP test of Maccura Biotechnology Co.,Ltd with 110 samples. The correlation coefficient(r) is 0.986.
BIBLIOGRAPHY
1. Morley JJ, Kushner (1982) Serum C-reactive protein levels in disease. In: Kushner I,
Volanakis JE, Gewurz H,eds. C-reactive protein and the plasma protein response to tissue injury. Ann. NY Acad. Sci. 389: 406-417.
2. Peltola HO (1982) C-reactive protein for rapid monitoring of infections of the central
nervous system. Lancet:980-983.
3. Macy EM, Hayes TE and Tracy RP (1997) Variability in the measurement of C-reactive
protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin. Chem. 43, 52-58.
use or consult
representative in the
damaged and consult
Statement: Information about manufacturer of Lancet is placed on the label. Distributed in Italy by PM2 Services Srl, Corso Mazzini 38- Largo Marchi, 36071 Arzignano (VI)
- info@pm2services.it
Number: F145107000 Revision date: 2022-09-19
sufficient for
Batch code
Use-by date
Manufacturer
Temperature limit
Do not re-use
Loading...